Advertisement

Picture EBD Group World of Partnering Opportunities 650x100px
Person › Details

Eduardo Bravo (TiGenix N.V. (Euronext + Nasdaq: TIG))

Bravo, Eduardo (Life Sciences Partners 202103– Partner + CEO of EBAC before Nordic Nanovector + TiGenix + Cellerix)

 

Organisation Organisation TiGenix N.V. (Euronext + Nasdaq: TIG)
  Group Takeda (Group)
Products Product Betalutin®
  Product 2 Cx621 (expanded allogenic stem cell product)
     

   
Record changed: 2023-03-09

Advertisement

Picture Berlin Partner Top News Captain T Cell Therapies 650x200px


More documents for Eduardo Bravo


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture EBD Group World of Partnering Opportunities 650x300px




» top